A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Conditions
- Crohn Disease
- Ulcerative Colitis
- Psoriasis
- Ankylosing Spondylitis
- Rheumatoid Arthritis
- Psoriatic Arthritis
Sponsor
Fresenius Kabi